Precision medicine
-
DATABASE (44)
-
ARTICLES (89)
Co-founder, CEO of Tonic App
Daniela Seixas is the Portuguese-born CEO and co-founder of Tonic App for medical doctors, where she has worked since 2016. She co-founded the company with three fellow students at IE Business School in Madrid during MBA studies in 2015. She was also a neuroradiologist in the Portuguese hospital Vila Nova de Gaia until 2017, when she dedicated herself full time to Tonic App. Seixas is additionally an independent expert on ethics and scientific evaluations at the European Commission and an affiliate professor at the University of Porto, where she studied for a PhD in Neuroscience and lectured in medicine.
Daniela Seixas is the Portuguese-born CEO and co-founder of Tonic App for medical doctors, where she has worked since 2016. She co-founded the company with three fellow students at IE Business School in Madrid during MBA studies in 2015. She was also a neuroradiologist in the Portuguese hospital Vila Nova de Gaia until 2017, when she dedicated herself full time to Tonic App. Seixas is additionally an independent expert on ethics and scientific evaluations at the European Commission and an affiliate professor at the University of Porto, where she studied for a PhD in Neuroscience and lectured in medicine.
BayWa Venture GmbH is a subsidiary company of BayWa AG, the German agriculture, energy and construction conglomerate.Putting digitalization at the core of its agriculture strategy, the company is looking to expand its core business into digital services within the existing businesses. It is investigating new digital business models and stand-alone concepts through collaboration with emerging startups focusing on cutting-edge technologies in the agrifood tech space.BayWa started to invest in startups in 2012 mainly focused on online customer management, services and sales platforms. In 2015, the company purchased Farm Facts, a German farm management SaaS and in 2017 invested in Abundant Robotics, a US-based automated harvest company. One of the firms’ most recent investments has been Evja, an Italian startup developing precision farming hardware based on advanced agronomic models and machine learning technology.
BayWa Venture GmbH is a subsidiary company of BayWa AG, the German agriculture, energy and construction conglomerate.Putting digitalization at the core of its agriculture strategy, the company is looking to expand its core business into digital services within the existing businesses. It is investigating new digital business models and stand-alone concepts through collaboration with emerging startups focusing on cutting-edge technologies in the agrifood tech space.BayWa started to invest in startups in 2012 mainly focused on online customer management, services and sales platforms. In 2015, the company purchased Farm Facts, a German farm management SaaS and in 2017 invested in Abundant Robotics, a US-based automated harvest company. One of the firms’ most recent investments has been Evja, an Italian startup developing precision farming hardware based on advanced agronomic models and machine learning technology.
Silicon Valley-based Almaz Capital was co-founded in 2008 as a bridge VC fund by Alexander Galitsky, a serial techpreneur and former senior executive at the Soviet Space Agency and Defense Industry. Almaz also has an office in Berlin and partners with interests in the UK, Poland and Ukraine. The global fund has invested in over 30 startups and managed 15 exits within its portfolio.Recent investments in 2021 include co-leading the $54m Series B round of Refurbed with Evli Growth Partners in August. Almaz was also the lead investor for the $6m funding round for US-based precision audio software Sonarworks in July.
Silicon Valley-based Almaz Capital was co-founded in 2008 as a bridge VC fund by Alexander Galitsky, a serial techpreneur and former senior executive at the Soviet Space Agency and Defense Industry. Almaz also has an office in Berlin and partners with interests in the UK, Poland and Ukraine. The global fund has invested in over 30 startups and managed 15 exits within its portfolio.Recent investments in 2021 include co-leading the $54m Series B round of Refurbed with Evli Growth Partners in August. Almaz was also the lead investor for the $6m funding round for US-based precision audio software Sonarworks in July.
Co-founder, Chief Medical Officer of Mediktor
Dr Oscar García-Esquirol is the Chief Medical Officer and co-founder of Mediktor, where he has also worked earlier as a machine trainer and digital doctor. He is currently also a director at the Barcelona Health Hub that promotes local digital healthtechs from its 2,500-sq m base at Barcelona's UNESCO-protected Modernist hospital, Hospital Sant Pau.Since 2000, he has been working as a critical care physician at Hospital Moisès Broggi in Spain. He also specialized in general medicine and surgery at the University of Barcelona. He continues to work in emergency, critical care and life support on a part-time basis.
Dr Oscar García-Esquirol is the Chief Medical Officer and co-founder of Mediktor, where he has also worked earlier as a machine trainer and digital doctor. He is currently also a director at the Barcelona Health Hub that promotes local digital healthtechs from its 2,500-sq m base at Barcelona's UNESCO-protected Modernist hospital, Hospital Sant Pau.Since 2000, he has been working as a critical care physician at Hospital Moisès Broggi in Spain. He also specialized in general medicine and surgery at the University of Barcelona. He continues to work in emergency, critical care and life support on a part-time basis.
Founder & President of Eimageglobal
As a graduate in Biomedical Engineering from Southeast University as well as Clinical Medicine from Nanjing Medical University, Chai Xueting has always been aware of the issues plaguing the traditional medical imaging system. The exorbitant cost of archiving past records and the lack of a comprehensive medical image sharing system between hospitals for a fully effective diagnosis have long raised concerns in his mind. But it was while taking his young daughter to the hospital for a health checkup, personally experiencing these issues, that Chai became ever more determined to build a cloud-based medical system – hence his founding of Eimageglobal. In 2017, Chai won the “Young Tech Giant” Award by Zhejiang Entrepreneur Committee.
As a graduate in Biomedical Engineering from Southeast University as well as Clinical Medicine from Nanjing Medical University, Chai Xueting has always been aware of the issues plaguing the traditional medical imaging system. The exorbitant cost of archiving past records and the lack of a comprehensive medical image sharing system between hospitals for a fully effective diagnosis have long raised concerns in his mind. But it was while taking his young daughter to the hospital for a health checkup, personally experiencing these issues, that Chai became ever more determined to build a cloud-based medical system – hence his founding of Eimageglobal. In 2017, Chai won the “Young Tech Giant” Award by Zhejiang Entrepreneur Committee.
Co-founder, CEO of UpHill
Freire Rodrigues is the Portuguese co-founder and CEO at UpHill, whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. He also continues to be an invited assistant teacher at Lisbon’s NOVA Medical School’s Faculty of Medical Sciences, where he completed a master’s in Medicine and worked full-time for three years prior to UpHill. He additionally collaborates in public healthcare at the ARSLVT healthcare company in Lisbon. He has worked as a resident physician at public hospitals in Lisbon and Paris.Freire Rodrigues also completed clinical scholars research training at Harvard Medical School and gained a qualification in Information Management and Business Intelligence in Healthcare at NOVA Information Management School in Lisbon.
Freire Rodrigues is the Portuguese co-founder and CEO at UpHill, whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. He also continues to be an invited assistant teacher at Lisbon’s NOVA Medical School’s Faculty of Medical Sciences, where he completed a master’s in Medicine and worked full-time for three years prior to UpHill. He additionally collaborates in public healthcare at the ARSLVT healthcare company in Lisbon. He has worked as a resident physician at public hospitals in Lisbon and Paris.Freire Rodrigues also completed clinical scholars research training at Harvard Medical School and gained a qualification in Information Management and Business Intelligence in Healthcare at NOVA Information Management School in Lisbon.
Co-founder of UpHill
Patrão is a Portuguese co-founder at UpHill whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. Despite being heavily involved in the development of the software Simulate, Patrão continues to work in the medical field full-time.He has spent the last decade working at Viseu’s Tondela Hospital Center in the intensive care unit as a physician. He also lectures part-time at his former university Beira Interior, where UpHill was established, and is a researcher for the RISRECP, the Colombia-based Iberian Network of Researchers in Renal Health and Common Chronic Illnesses.The co-founder also helps produce clinical simulations for producer Hands on Education and holds a doctorate in Medicine from Beira Interior University.
Patrão is a Portuguese co-founder at UpHill whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. Despite being heavily involved in the development of the software Simulate, Patrão continues to work in the medical field full-time.He has spent the last decade working at Viseu’s Tondela Hospital Center in the intensive care unit as a physician. He also lectures part-time at his former university Beira Interior, where UpHill was established, and is a researcher for the RISRECP, the Colombia-based Iberian Network of Researchers in Renal Health and Common Chronic Illnesses.The co-founder also helps produce clinical simulations for producer Hands on Education and holds a doctorate in Medicine from Beira Interior University.
CTO and co-founder of IOMED Medical Solutions
Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding.
Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding.
CSO and co-founder of iLoF
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
Co-founder, CEO of Rheaply
Garry Cooper is the CEO and co-founder of pioneering circular economy B2B asset reuse platform Rheaply where he has worked full-time since 2016. Before that, he worked in research for over 10 years at Chicago’s Northwestern University Feinburg School of Medicine, leading Parkinson's disease treatment investigation there for four years and, before that, as a graduate student researcher. He also temporarily served as a member of the Life Science Practice R&D division at consultancy EY, during this time. Cooper holds a PhD in neuroscience from Northwestern University, a Bachelor’s degree in Mathematics from Indiana University Bloomington and a Certificate in Management for Scientists and Engineers from the Kellogg School of Management. Cooper also continues to be an adjunct assistant professor at Northwestern University and a member of several local business associations, including the Economic Club of Chicago, Forbes Chicago Business Council and 1871.
Garry Cooper is the CEO and co-founder of pioneering circular economy B2B asset reuse platform Rheaply where he has worked full-time since 2016. Before that, he worked in research for over 10 years at Chicago’s Northwestern University Feinburg School of Medicine, leading Parkinson's disease treatment investigation there for four years and, before that, as a graduate student researcher. He also temporarily served as a member of the Life Science Practice R&D division at consultancy EY, during this time. Cooper holds a PhD in neuroscience from Northwestern University, a Bachelor’s degree in Mathematics from Indiana University Bloomington and a Certificate in Management for Scientists and Engineers from the Kellogg School of Management. Cooper also continues to be an adjunct assistant professor at Northwestern University and a member of several local business associations, including the Economic Club of Chicago, Forbes Chicago Business Council and 1871.
CTO and co-founder of iLoF
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Co-founder of Therapixal
Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.
Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
COO and co-founder of iLoF
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
Raising $50m second fund, Indogen Capital seeks more international partners and exits
Cooperation is key to Indogen's investment thesis, as it looks to help more foreign VCs and their portfolio startups find success in Southeast Asia's biggest market
Autodrive Solutions: Making driverless vehicles safer with high-precision positioning tech
A Spanish university's research on sophisticated weapons detection technology is being used to prevent accidents in the mobility and transport sectors
In-store robots and online doctors serve customers 24/7 at Dingdang Medicine Express
Dingdang also offers cheaper medicines and 28-minute home delivery, thanks to its innovative logistics and partnership models
QinLin Tech gets advertisers to pay for your local security systems
Besides keeping residents safe from intruders, QinLin’s smart community business model also offers essential home services, social activities and group-buying discounts
China's WeDoctor offers free coronavirus consultations globally in English and Chinese
WeDoctor lets anyone in the world send queries to doctors who fought to save lives in China's most affected Covid-19 districts, and now helping people overseas to stay safe during the pandemic
TMiRob's medical robots lighten the load of doctors and nurses in hospitals
The robots also reach an operating room three minutes faster than human nurses – that's more time for saving lives
From Naples to Dhaka: Italo-Dutch precision farming startup Evja eyes funding for R&D, sales boost
Evja has a second office in the Dutch “Food Valley” and is investing to boost its advanced agronomic modeling, to stave off rising competition
UpHill: Helping doctors put the latest research into practice
Born out of practitioners’ difficulty in keeping up with latest treatments and protocols, UpHill now includes guidance on Covid-19
For crop pest control, McFly does all the thinking
Chinese agtech startup McFly deploys data-driven crop health and pesticide monitoring systems so farmers get higher-quality yields and less wastage
BeeHero: Agritech for bee health and better crop pollination
Combining AI, smart sensors and the world’s largest bee database, BeeHero accurately predicts disorders in colonies, helping beekeepers reduce the mortality rate of bees vital for crop pollination
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
HEMAV: World’s leading drone services company for agriculture
Now a global leader known for its industry-targeted software, HEMAV has expanded to 15 countries, working with utilities, farms and public bodies
Benergy: A new app to track gut health with smart data
The Benergy app allows results to be shared with doctors to facilitate diagnosis and includes swap tests
Sorry, we couldn’t find any matches for“Precision medicine”.
POPULAR DATABASE
